Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients undergoing alcohol withdrawal in the intensive care unit (ICU) often require escalating doses of benzodiazepines and not uncommonly require intubation and mechanical ventilation for airway protection. This may lead to complications and prolonged ICU stays. Experimental studies and single case reports suggest the α2-agonist dexmedetomidine is effective in managing the autonomic symptoms seen with alcohol withdrawal. We report a retrospective analysis of 20 ICU patients treated with dexmedetomidine for benzodiazepine-refractory alcohol withdrawal. METHODS: Records from a 23-bed mixed medical-surgical ICU were abstracted from November 2008 to November 2010 for patients who received dexmedetomidine for alcohol withdrawal. The main analysis compared alcohol withdrawal severity scores and medication doses for 24 h before dexmedetomidine therapy with values during the first 24 h of dexmedetomidine therapy. RESULTS: There was a 61.5% reduction in benzodiazepine dosing after initiation of dexmedetomidine (n = 17; p < 0.001) and a 21.1% reduction in alcohol withdrawal severity score (n = 11; p = .015). Patients experienced less tachycardia and systolic hypertension following dexmedetomidine initiation. One patient out of 20 required intubation. A serious adverse effect occurred in one patient, in whom dexmedetomidine was discontinued for two 9-second asystolic pauses noted on telemetry. CONCLUSIONS: This observational study suggests that dexmedetomidine therapy for severe alcohol withdrawal is associated with substantially reduced benzodiazepine dosing, a decrease in alcohol withdrawal scoring and blunted hyperadrenergic cardiovascular response to ethanol abstinence. In this series, there was a low rate of mechanical ventilation associated with the above strategy. One of 20 patients suffered two 9-second asystolic pauses, which did not recur after dexmedetomidine discontinuation. Prospective trials are warranted to compare adjunct treatment with dexmedetomidine versus standard benzodiazepine therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434
Role of α 2 -Agonists in the Treatment of Acute Alcohol Withdrawal
Muzyk, A. J., Fowler, J. A., Norwood, D. K., & Chilipko, A. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p575 · Cited by 107
Cited by
Delirium Tremens: Assessment and Management
Grover, S., & Ghosh, A. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.04.012 · Cited by 416
Recognition and Management of Withdrawal Delirium (Delirium Tremens)
Schuckit, M. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1407298 · Cited by 374
Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature
Brotherton, A. L., Hamilton, E. P., Kloss, H. G., & Hammond, D. A. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1726 · Cited by 51
Mo, Y., Thomas, M. C., & Karras, G. E. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.11.022 · Cited by 47
Shah, P., McDowell, M., Ebisu, R., Hanif, T., & Toerne, T. (2018) · Journal of Medical Toxicology · doi:10.1007/s13181-018-0662-8 · Cited by 46
Metadata
- Authors
- Rayner, S. G., Weinert, C. R., Peng, H., Jepsen, S., Broccard, A. F., & Institution, S.
- Venue
- Annals of Intensive Care
- Publisher
- Elsevier BV
- Published
- 2012
- Volume
- 2
- Issue
- 1
- Pages
- 12
- ISSN
- 2110-5820 (ISSN-L)
- OpenAlex
- W2143780481
- Cited by
- 101
- References
- 3
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. https://app.cochat.ai/papers/10.1186/2110-5820-2-12
- The paper
- Rayner, S. G., Weinert, C. R., Peng, H., Jepsen, S., Broccard, A. F., & Institution, S. (2012). Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Annals of Intensive Care. https://doi.org/10.1186/2110-5820-2-12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.